Not exact matches
In the new issue of Inc., I
talked to the billionaire venture capitalist
about why he's been putting so much of his time and money into biotech startups, particularly those focused on health and
human biology.
«Everything we
talked about was
about research directly on the embryo,» for example, to improve on infertility treatment or better understand cancer
biology, says R. Alta Charo, a law professor and bioethicist at the University of Wisconsin Law School who was a member of the NIH
Human Embryo Research Panel in the mid-1990s, which considered how embryos might be used in research.
He was fascinated by a
talk one of his engineering professors gave
about high - performance computing in the
Human Genome Project, and he began to see other connections between
biology and engineering.